000			02360 a2200673 4500
005			20250515185328.0
264		0	_c20100304
008			201003s 0 0 eng d
022			_a1460-2180
024	7		_a10.1093/carcin/bgp222 _2doi
040			_aNLM _beng _cNLM
100	1		_aIshida, Masaru
245	0	0	_aActivation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. _h[electronic resource]
260			_bCarcinogenesis _cFeb 2010
300			_a287-95 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aApoptosis
650	0	4	_aAryl Hydrocarbon Hydroxylases
650	0	4	_aBlotting, Western
650	0	4	_aCarcinoma, Transitional Cell _xmetabolism
650	0	4	_aCell Adhesion
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement
650	0	4	_aCell Proliferation
650	0	4	_aCytochrome P-450 CYP1A1 _xgenetics
650	0	4	_aCytochrome P-450 CYP1B1
650	0	4	_aCytochrome P-450 Enzyme System _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aKidney Neoplasms _xmetabolism
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinase 1 _xmetabolism
650	0	4	_aMatrix Metalloproteinase 9 _xmetabolism
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aPolychlorinated Dibenzodioxins _xpharmacology
650	0	4	_aPrognosis
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRNA, Small Interfering _xpharmacology
650	0	4	_aReceptors, Aryl Hydrocarbon _xantagonists & inhibitors
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSurvival Rate
650	0	4	_aUreteral Neoplasms _xmetabolism
650	0	4	_aUrothelium _xmetabolism
700	1		_aMikami, Shuji
700	1		_aKikuchi, Eiji
700	1		_aKosaka, Takeo
700	1		_aMiyajima, Akira
700	1		_aNakagawa, Ken
700	1		_aMukai, Makio
700	1		_aOkada, Yasunori
700	1		_aOya, Mototsugu
773	0		_tCarcinogenesis _gvol. 31 _gno. 2 _gp. 287-95
856	4	0	_uhttps://doi.org/10.1093/carcin/bgp222 _zAvailable from publisher's website
999			_c19153443 _d19153443